BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyazaki Y, Tsutsui T, Inase N. Treatment and monitoring of hypersensitivity pneumonitis. Expert Review of Clinical Immunology 2016;12:953-62. [DOI: 10.1080/1744666x.2016.1182426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Willemsen AECAB, Tol J, van Erp NP, Jonker MA, de Boer M, Meek B, de Jong PC, van Moorsel C, Gerritsen WR, Grutters JC, van Herpen CML. Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane. Target Oncol 2019;14:441-51. [PMID: 31325105 DOI: 10.1007/s11523-019-00656-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ejima M, Okamoto T, Suzuki T, Miyazaki Y. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis. Respir Investig 2022:S2212-5345(21)00217-3. [PMID: 34998715 DOI: 10.1016/j.resinv.2021.12.003] [Reference Citation Analysis]
3 Nukui Y, Yamana T, Masuo M, Tateishi T, Kishino M, Tateishi U, Tomita M, Hasegawa T, Aritsu T, Miyazaki Y. Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis. PLoS One 2019;14:e0220462. [PMID: 31369605 DOI: 10.1371/journal.pone.0220462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Mudawi D, Heyes K, Hastings R, Rivera-Ortega P, Chaudhuri N. An update on interstitial lung disease. Br J Hosp Med (Lond) 2021;82:1-14. [PMID: 34338019 DOI: 10.12968/hmed.2020.0556] [Reference Citation Analysis]
5 Murakami T, Iijima Y, Ando T, Ejima M, Shirai T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Miyazaki Y. Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report. Respiratory Medicine Case Reports 2022. [DOI: 10.1016/j.rmcr.2022.101639] [Reference Citation Analysis]
6 Ejima M, Okamoto T, Suzuki T, Anzai T, Takahashi K, Miyazaki Y. Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis. BMC Pulm Med 2021;21:243. [PMID: 34281549 DOI: 10.1186/s12890-021-01608-1] [Reference Citation Analysis]
7 Tanguy J, Pommerolle L, Garrido C, Kolb M, Bonniaud P, Goirand F, Bellaye PS. Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases. Int J Mol Sci 2021;22:9316. [PMID: 34502225 DOI: 10.3390/ijms22179316] [Reference Citation Analysis]
8 Sema M, Miyazaki Y, Tsutsui T, Tomita M, Eishi Y, Inase N. Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance. Immun Inflamm Dis 2018;6:154-62. [PMID: 29168324 DOI: 10.1002/iid3.202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
9 Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P, Guzman J, Ryerson CJ, Selman M. Hypersensitivity pneumonitis. Nat Rev Dis Primers 2020;6:65. [PMID: 32764620 DOI: 10.1038/s41572-020-0191-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]